MOCKSVILLE, N.C., Feb. 06, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have ...

22nd Century Group, Inc. announced its support for the FDA's proposed standard to reduce nicotine content in cigarettes, which recently cleared review by the Office of Management and Budget.

17:02 EST 22nd Century (XXII) files to sell 104,124 shares of common stock for holders Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news.

Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Shares of NASDAQ:XXII opened at $5.10 on Friday. 22nd Century Group has a 1 year low of $3.90 and a 1 year high of $581.85. The company has a debt-to-equity ratio of 1.59, a current ratio of 1.09 ...

22nd Century announces readiness to support the FDA's proposed standard to reduce nicotine content in cigarettes. The possible regulation passed review by the U.S. Office of Management and Budget ...

Shares of 22nd Century Group Inc. ($XXII), a tobacco products-focused company, rose nearly 22% on Monday as a U.S. Food and Drug Administration proposal to mandate ...

22nd Century (XXII) Group stands ready to support the U.S. Food and Drug Administration’s proposed tobacco product standard to mandate reduced nicotine content in cigarettes, which is indicated ...

0T5.F Turning Point Brands, Inc.